Skip to main content

Table 1 Clinical and demographic characteristics of participants

From: In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

 

CN (n = 8)

MCI (n = 9)

AD (n = 26)

Age at scan, mean (SD)

77.1 (6.2)

80.3 (9.7)

75.5 (6.8)

Women, N (%)

3 (37.5)

1 (11.1)

10 (38.5)

Education, mean (SD) years

15.4 (3.1)

16.1 (2.7)

15.8 (2.7)

APOE ε4 carriers (%)

2 (25)

3 (33.3)

19 (73.1) a,b

MMSE, mean (SD)

28.7 (1.2)

26.1 (2.8)

21.9 (4.6) a,b

GDS, mean (SD)

0.9 (0.9)

3.6 (3.9)

2.9 (3.2)

Global CDR®, mean (SD)

0.0 (0)

0.8 (0.5) a

1.0 (0.4) a

CDR-SB, mean (SD)

0.0 (0)

3.8 (3.2) a

5.7 (2.2) a,b

MRI scan/autopsy interval, mean (SD) days

1508.6 (967.6)

1368.2 (879.9)

1531.9 (884.3)

Diagnostic changes by 36 months

3 (to MCI)

8 (to AD)

0

  1. ANOVA was used to identify differences between diagnostic groups
  2. APOE apolipoprotein E, MMSE Mini-Mental State Examination, GDS Geriatric Depression Rating Scale, CDR Clinical Dementia Rating scale global, CDR-SB Clinical Dementia Rating scale sum of boxes (available only for NACC participants)
  3. aSignificant difference from CN
  4. bSignificant difference from MCI